Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007918
Filing Date
2016-08-11
Accepted
2016-08-11 16:29:48
Documents
55
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20160630x10q.htm 10-Q 1335903
2 EX-31.1 vygr-20160630ex311df27a5.htm EX-31.1 21242
3 EX-31.2 vygr-20160630ex3122a9aed.htm EX-31.2 20293
4 EX-32.1 vygr-20160630ex321140cfa.htm EX-32.1 16095
5 GRAPHIC vygr20160630x10q001.jpg GRAPHIC 112662
  Complete submission text file 0001558370-16-007918.txt   5510986

Data Files

Seq Description Document Type Size
6 EX-101.INS vygr-20160630.xml EX-101.INS 1135202
7 EX-101.SCH vygr-20160630.xsd EX-101.SCH 40539
8 EX-101.CAL vygr-20160630_cal.xml EX-101.CAL 47567
9 EX-101.DEF vygr-20160630_def.xml EX-101.DEF 158964
10 EX-101.LAB vygr-20160630_lab.xml EX-101.LAB 350414
11 EX-101.PRE vygr-20160630_pre.xml EX-101.PRE 280920
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 161824951
SIC: 2836 Biological Products, (No Diagnostic Substances)